The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly twofold, with females more likely than males to report feeling either ...

In reducing federal funding and downsizing federal health agencies, the Trump administration is impeding cancer research.